Earlier, the USPTO published an Official Gazette notice in November of 1996 providing a partial waiver of the requirements for restriction and for unity of invention determinations. The 1996 Notice permitted examination of a reasonable number (reasonable being normally up to ten, independent and distinct molecules).
Now, in their quest to reduce patent application pendency times [...]
President Bush gave out an early Christmas present to the biotech industry on Tuesday after signing a bill that creates a somewhat controversial bureaucracy that would give tax dollars to private companies and universities to develop vaccines and treatments. The bill, the “Pandemic and All-Hazards Preparedness Act” (S. 3678) creates the Biomedical Advanced Research and [...]
A jury rejected the claims of Kourosh Dastgheib, an ophthalmologist who accused Genentech of reneging on a promise to pay him royalties from the drug in exchange for his research slides of human eye specimens. Dastgheib v. Genentech Inc., U.S. District Court, Eastern District of Pennsylvania (04CV01283).
While Dastgheib’s lawyers said he was entitled to [...]
The U.S. Patent and Trademark Office (USPTO) announced it will re-examine patents covering embryonic stem cell discoveries made by University of Wisconsin researchers. The patents, US Pat. Nos. 5,843,780, 6,200,806, and 7,029,913, cover all embryonic stem cell research in the U.S. The USPTO could revoke, modify or leave intact the patents but any [...]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
